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Hip fracture is a leading cause of death and dis-
ability among the elderly worldwide.1,2 The inci-
dence is rising as populations age, and there are 
now over 1.6 million hip fractures globally each 
year.1 In the United Kingdom alone, there are 
70 000 cases annually at a cost of £2 billion.3
Pay-for-performance initiatives are increasingly 
used to improve outcomes.4-6 These schemes link 
healthcare payments to quality metrics in order 
to incentivize providers to improve the quality or 
efficiency of care.7 There is mixed evidence about 
whether these initiatives can truly drive improve-
ments in healthcare.4,6 There is evidence that 
they can modestly improve care. However, few 
pay-for-performance schemes have been shown to 
positively affect outcomes.6
A national clinical audit was established in 
England and Wales in 2007 with the aim of improv-
ing hip fracture outcomes.8 This programme 
included a National Hip Fracture Database (NHFD) 
and support for local clinical teams to improve the 
quality of care provided to elderly patients with a 
hip fracture. In 2010, the NHFD was the basis for 
a pay-for-performance initiative, called the ‘Best 
Practice Tariff’ (BPT). The BPT scheme paid hos-
pitals a supplement for each patient whose care sat-
isfied six clinical standards, such as surgery within 
36 hours.9 Cases satisfying these standards, which 
have evolved over time (Supplementary Table i), 
were identified from data submitted to the NHFD. 
Importantly, Scottish hospitals did not participate in 
the NHFD and were not subject to the BPT.
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Aims
Hip fractures are associated with high morbidity, mortality, and costs. One strategy for 
improving outcomes is to incentivize hospitals to provide better quality of care. We aimed 
to determine whether a pay-for-performance initiative affected hip fracture outcomes in 
England by using Scotland, which did not participate in the scheme, as a control.
Materials and Methods
We undertook an interrupted time series study with data from all patients aged 
more than 60 years with a hip fracture in England (2000 to 2018) using the Hospital 
Episode Statistics Admitted Patient Care (HES APC) data set linked to national death 
registrations. Difference-in-differences (DID) analysis incorporating equivalent data from 
the Scottish Morbidity Record was used to control for secular trends. The outcomes were 
30-day and 365-day mortality, 30-day re-admission, time to operation, and acute length 
of stay.
Results
There were 1 037 860 patients with a hip fracture in England and 116 594 in Scotland. Both 
30-day (DID -1.7%; 95% confidence interval (CI) -2.0 to -1.2) and 365-day (-1.9%; 95% CI 
-2.5 to -1.3) mortality fell in England post-intervention when compared with outcomes in 
Scotland. There were 7600 fewer deaths between 2010 and 2016 that could be attributed 
to interventions driven by pay-for-performance. A pre-existing annual trend towards 
increased 30-day re-admissions in England was halted post-intervention. Significant 
reductions were observed in the time to operation and length of stay.
Conclusion
This study provides evidence that a pay-for-performance programme improved the 
outcomes after a hip fracture in England.
Cite this article: Bone Joint J 2019;101-B:1015–1023.
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This study aimed: first to quantify any effect of the NHFD 
and BPT on the outcomes of hip fractures in England using 
data from Scotland to control for secular trends; and second to 
estimate the effect of introducing pay-for-performance for hip 
fractures in Scotland.
Materials and Methods
This study was a natural experiment using interrupted time 
series10 and difference-in-differences (DID) analysis.11 It 
relied on national data from two sources in order to conduct 
quasi- experimental modelling of temporal trends. Changes in 
 England, where the NHFD/BPT was introduced, were ana-
lyzed as an ‘exposed’ group and those in Scotland as a ‘con-
trol’. Given the countries’ geographical proximity, cultural 
similarities, and common political union within the United 
Kingdom, it was anticipated that secular changes in Scotland 
would closely mimic those in England had the NHFD/BPT not 
been implemented.12
Data for England were abstracted from the Hospital Episode 
Statistics Admitted Patient Care (HES APC) data set13 linked to 
Office for National Statistics (ONS) death certificate registra-
tions. Data for Scotland were abstracted from Scottish Morbidity 
Records (SMR01).14
The HES APC data set is managed by NHS Digital and col-
lects data on all admissions to National Health Service (NHS) 
hospitals, as well as those treated in private hospitals but funded 
by the NHS.13 Approximately 98% of hospital activity in 
England is funded by the NHS.15 It is unlikely that many elderly 
patients with a hip fracture were treated in the private sector 
during the study period. The HES APC data does not include 
information about Emergency Department attendances that do 
not lead to admission.13
The ONS holds data on all deaths registered in England and 
Wales. All English deaths should be captured, although reg-
istration could be delayed in cases referred to a coroner for 
post-mortem or inquest. In 2016, upwards of 96% of deaths 
were registered within the year that they occurred.16
The SMR collects administrative data on episodes of inpa-
tient care provided by all hospitals in Scotland. It is managed 
by the Information Services Division (ISD) for NHS National 
Services Scotland and is linked directly to Scottish death certif-
icate data. ISD Scotland estimate that the SMR01 captures 99% 
of admissions to hospitals in Scotland.17
The United Kingdom is a unitary state composed of four 
countries: England, Scotland, Wales, and Northern Ireland. 
Comprehensive publicly funded healthcare is freely available 
throughout the United Kingdom under the NHS. Provision of 
healthcare under the auspices of NHS Scotland was devolved to 
the Scottish Parliament by the Scotland Act 1998.18
All adults aged more than 60 years were included in the 
analysis if they were treated for a hip fracture in England or 
Scotland with inpatient admission dates between January 2000 
and December 2016 and had complete follow-up information 
for a period of one year following admission (2000 to 2017). 
No additional exclusion criteria were applied. Patients had to 
present with a primary International Classification for Dis-
eases, Tenth Revision (ICD-10) diagnostic code19 on admis-
sion consistent with: S72.0 (“fracture of neck of femur”), 
S71.1 (“pertrochanteric fracture”), or S72.2 (“subtrochanteric 
fracture”).
The principal aim of the study was to determine the effect of 
introducing a pay-for-performance initiative on outcomes for 
elderly patients with a hip fracture. However, the Hip Fracture 
BPT was only feasible once a framework had been established 
for capturing high-quality clinical audit data. This framework 
was provided by the National Hip Fracture Database (NHFD), 
which was launched three years previously. We therefore exam-
ined the effect: first of the introduction of the NHFD from 
January 2007; second of the introduction of the Hip Fracture 
BPT from April 2010; and third of the combined effect of the 
NHFD/BPT intervention.
The NHFD was launched in 2007 and captures data on most 
adults aged more than 60 years with a hip fracture treated in 
England, Wales, and Northern Ireland.8 All acute hospitals 
treating hip fractures in England, Wales, and Northern Ireland 
contribute data to the NHFD.8 In addition to publicly reporting 
hospital-level outcomes in an annual report, the NHFD pro-
vides an online platform, through which clinical teams can vis-
ualize their outcomes and performance and compare them with 
national clinical standards.9 These standards have changed over 
time (Supplementary Table i).
All NHS hospitals are reimbursed by a system of tariffs 
based on an adjusted formula applied to the “reference costs” 
returned by NHS organizations that estimate the cost of treating 
patients the previous year. In order to achieve the Hip Fracture 
BPT, hospitals must satisfy all the criteria shown in Supple-
mentary Table i. The NHFD reports patient-level compliance 
with the national standards to the local Clinical Commissioning 
Group (CCG),20 which makes a quarterly correction payment to 
individual hospitals.
The primary outcome was 30-day mortality. Secondary out-
comes included 60-, 90-, and 365-day mortality as well as 30-, 
60-, and 90-day re-admission, time to operation (defined as 
binary early time to the operating room of less than or more 
than two days), and acute length of stay (LOS) in days.
Statistical analysis. Differences in demographic and clini-
cal variables were compared between countries before and 
after the introduction of the NHFD and BPT in 2007 to 2010, 
respectively, in order to visualize potential differences between 
groups. The ‘pre-intervention’ period was defined as 1 January 
2000 to 31 December 2006 and the ‘post-intervention’ period 
was defined as 1 May 2010 to 1 February 2018. Patients admit-
ted in the period between 1 January 2007 and 30 April 2010 
were incorporated into stepwise analyses examining changes 
before and after establishment of the NHFD and the BPT. 
Covariate information, presented in Table I, was largely con-
sistent between groups with subtle time-consistent differences 
in admitted hip fracture patients in England and Scotland.
Changes in hip fracture outcomes in England and Scotland 
were first visualized graphically by month in order to detect 
obvious changes and ensure the existence of pre-intervention 
parallel trends, which is a requirement of quasi-experimental 
DID analysis. These visualizations included scatter plots with 
locally weighted smoothing (LOWESS) lines, which are smooth 
lines created using regression analysis to help visualize trends 
over time.
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The quantitative assessment of before-and-after changes 
was also undertaken for English data using interrupted time 
series analysis (ITSA). ITSA was used to contextualize the 
main DID results for mortality and to account for changes in 
English outcomes not reported in Scottish data, such as time to 
operation. ITSA functions by fitting linear regression models to 
observations from the pre- and post-intervention periods. For 
the purposes of ITSA analysis, longitudinal patient-level data 
were aggregated into monthly bins for each month of the year 
and were plotted by month as the proportion (or indicated quan-
tile of initial LOS) of each outcome of interest. Analyses were 
based on 84 pre-intervention points (patients admitted between 
January 2000 and December 2006) and 81 post- intervention 
points (patients admitted between April 2010 and  December 
2016). Models estimated the pre-intervention trend (‘pre- 
intervention annual change’), change in level immediately 
following the intervention (‘instant change’) and change in post- 
intervention trend (‘post-intervention annual change’). The pres-
ence of autocorrelation was tested using the Durbin–Watson test. 
The extent to which the intercept of the post-intervention model 
deviates from the anticipated pre-intervention trend is assumed 
to represent an instantaneous causal effect of the intervention 
taking place during the same period of time. Ongoing changes 
during the post-intervention period, the post-intervention slope, 
can sometimes be observed as a marked and maintained change 
from pre-intervention trends.
Differences in outcomes for mortality for England and 
Scotland were further compared using DID regression. This 
quasi-experimental technique functions by fitting linear models to 
temporally aggregated data from the pre- and post-intervention 
periods. It includes coefficients for intervention group (e.g. 
England vs Scotland), time period (e.g. pre- vs post-interven-
tion) and an interaction term between an intervention group and 
a period of time. The magnitude and direction of the interaction 
term (the so-called DID between temporal changes within each 
country) is assumed to represent the causal effect.12
Software: StataIC v.15.0 (StataCorp, College Station, Texas) 
was used for all statistical analyses. Panel data for ITSA were 
constructed from the admission-level master data set using col-
lapse commands. They were analyzed using the ITSA module21 
in Stata. The DIFF module22 was used for linear DID regression 
in order to obtain p-values and country-specific and time period- 
specific tabulations for tables; 95% confidence intervals (CI) 
were obtained by manually fitted versions of the same models.
The use of HES data for this project was approved by the 
NHS Digital Independent Group Advising on the Release of 
Data. NHS Digital undertook the linkage to ONS data and cre-
ated mortality flags at defined timepoints. Pseudo-anonymized 
Table I. Differences in demographic parameters before and after implementation in England and Scotland
Overall Pre-intervention:  
January 2000 to December 2006
Post-intervention:  
April 2010 to December 2016
Variable England Scotland England Scotland England Scotland
Hip fractures, n (%) 1 037 860 (89.9) 116 594 (10.1) 391 697 (89.4) 46 404 (10.6) 446 098 (90.3) 47 730 (9.7)
Age, n (%)
60 to 64 yrs 30 454 (2.9) 5071 (4.3) 10 225 (2.6) 1889 (4.1) 13 692 (3.1) 2115 (4.4)
65 to 69 yrs 49 178 (4.7) 7646 (6.6) 17 336 (4.4) 2978 (6.4) 23 178 (5.2) 3176 (6.7)
70 to 74 yrs 83 750 (8.1) 12 308 (10.6) 33 538 (8.6) 5236 (11.3) 34 752 (7.8) 4767 (10.0)
75 to 79 yrs 152 778 (14.7) 19 502 (16.7) 63 205 (16.1) 8170 (17.6) 60 507 (13.6) 7605 (15.9)
80 to 84 yrs 240 553 (23.2) 26 397 (22.6) 96 160 (24.5) 10 642 (22.9) 97 993 (22.0) 10 691 (22.4)
85 to 89 yrs 259 565 (25.0) 25 767 (22.1) 92 498 (23.6) 9813 (21.1) 113 854 (25.5) 10 825 (22.7)
≥ 90 yrs 221 582 (21.3) 19 903 (17.1) 78 735 (20.1) 7676 (16.5) 102 122 (22.9) 8551 (17.9)
Sex, n (%)
Male 256 703 (24.7) 29 141 (25.0) 84 411 (21.6) 10 426 (22.5) 112 404 (25.2) 12 927 (27.1)
Female 781 157 (75.3) 87 453 (75.0) 307 286 (78.4) 35 978 (77.5) 323 694 (72.6) 34 803 (72.9)
Multiple deprivation index, n (%)
Least deprived 10% 94 045 (9.1) N/A 32 649 (8.3) N/A 42 881 (9.6) N/A
Less deprived 10% to 20% 105 647 (10.2) N/A 38 843 (9.9) N/A 46 275 (10.4) N/A
Less deprived 20% to 30% 109 502 (10.6) N/A 40 488 (10.3) N/A 48 010 (10.8) N/A
Less deprived 30% to 40% 113 209 (10.9) N/A 41 918 (10.7) N/A 49 311 (11.1) N/A
Less deprived 40% to 50% 115 604 (11.1) N/A 43 150 (11.0) N/A 50 517 (11.3) N/A
More deprived 40% to 50% 112 110 (10.8) N/A 42 733 (10.9) N/A 48 052 (10.8) N/A
More deprived 30% to 40% 104 486 (10.1) N/A 39 906 (10.2) N/A 44 443 (10.0) N/A
More deprived 20% to 30% 99 736 (9.6) N/A 38 543 (9.8) N/A 41 805 (9.4) N/A
More deprived 10% to 20% 92 699 (8.9) N/A 36 962 (9.4) N/A 37 803 (8.5) N/A
Most deprived 10% 90 822 (8.8) N/A 36 505 (9.3) N/A 37 001 (8.3) N/A
Charlson Comorbidity  
Index, n (%)
One-year  
look back
Hospital  
reported
One-year  
look back
Hospital  
reported
One-year  
look back
Hospital  
reported
0 465 976 (44.9) 102 874 (88.2) 229 389 (58.6) 40 917 (88.2) 143 451 (32.2) 42 178 (88.4)
1 309 067 (29.8) 9331 (8.0) 104 123 (26.6) 3805 (8.2) 140 969 (31.6) 3774 (7.9)
2 139 411 (13.4) 3583 (3.1) 36 722 (9.4) 1387 (3.0) 77 399 (17.4) 1444 (3.0)
≥ 3 123 406 (11.9) 806 (0.7) 21 463 (5.5) 295 (0.6) 84 279 (18.9) 334 (0.7)
N/A, not applicable
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data were then transmitted to researchers at the University of 
Oxford. The Information Services Division of National Ser-
vices Scotland provided pseudo-anonymized records from the 
Scottish Morbidity Record Scheme. Ethical approval was not 
sought in line with GAFReC guidance.23 Personal data were 
processed under Articles 6(1)(f) and 9(2)(f) of the General Data 
Protection Regulation (EU) 2016/679.
This research was undertaken independently of the authors’ 
funding bodies, which did not have any influence on the study 
design, analysis, data interpretation, or decision to publish.
Results
A total of 1 037 860 adults aged more than 60 years were admit-
ted between 2000 and 2016 with a hip fracture in England, and 
116 594 in Scotland. The demographic characteristics of these 
groups are shown in Table I. Table II presents the ITSA results 
of English data, and Table III shows the more detailed DID 
analyses for mortality that include Scotland as a comparison 
group. 
Figure 1a shows that the pre-intervention trends in 30-day 
mortality were the same in England and Scotland; 30-day mor-
tality trended downwards in both countries after the launch of 
the NHFD, although the decline was more pronounced in Eng-
land. The diverging lines became more obvious after April 2010 
and this continued until the data were censored in December 
2016 (ITSA instant change following combined policy imple-
mentation -2.6 percentage points (95% CI -3.4 to -1.7); annual 
trend post-implementation -0.2 (-0.2 to -0.1). DID analysis 
Table II. Interrupted time-series analysis (ITSA) results before and after implementation among adults aged more than 60 years in England, 2000 
to 2016. ITSA compared differences in English temporal trends before (January 2000 to December 2006) and after (April 2010 to December 2016) 
combined policy implementation in 2007 to 2010
Annual trend  
pre-implementation
95% CI Instant  
change
95% CI p-value Annual trend  
post-implementation
95% CI
Mortality, %
30-day 0.0 -0.1 to 0.2 2.6 -3.4 to -1.7 < 0.001 -0.2 -0.2 to -0.1
60-day 0.1 0.0 to 0.3 -4.3 -5.5 to -3.1 < 0.001 -0.2 -0.4 to -0.1
90-day 0.2 0.0 to 0.4 -5.4 -6.8 to -4.1 < 0.001 -0.2 -0.4 to -0.1
365-day 0.2 0.1 to 0.4 -5.3 -6.3 to -4.2 < 0.001 -0.1 -0.2 to 0.0
Re-admission, %
30-day 0.4 0.3 to 0.5 -1.3 -2.2 to -0.5 0.003 -0.2 -0.4 to -0.1
60-day 0.7 0.5 to 0.8 -1.4 -2.3 to -0.5 0.002 -0.1 -0.1 to 0.0
90-day 0.8 0.6 to 0.9 -1.2 -2.1 to -0.2 0.015 0.0 -0.1 to 0.1
Length of stay
50th percentile (median) -0.1 -0.2 to 0.0 -2.8 -3.5 to -2.1 < 0.001 -0.4 -0.5 to -0.3
60th percentile -0.1 -0.2 to 0.0 -3.8 -4.6 to -3.1 < 0.001 -0.5 -0.7 to -0.4
70th percentile -0.1 -0.3 to 0.0 -5.4 -6.4 to -0.3 < 0.001 -0.7 -0.8 to -0.5
80th percentile -0.3 -0.5 to -0.1 -7.3 -8.8 to -5.8 < 0.001 -1.0 -1.2 to -0.8
Early time to theatre, % -0.6 -0.9 to -0.4 15.4 13.7 to 17.0 < 0.001 0.7 0.5 to 0.8
CI, confidence interval
Table III. Difference-in-difference (DID) results before and after Best Practice Tariff (BPT) implementation among adults aged more than 60 years, 
2000 to 2016. DID compared differences in mortality trends before (January 2000 to December 2006) and after (April 2010 to December 2016) com-
bined policy implementation in 2007 to 2010 in England versus Scotland, ‘intervention overall’. They also broke down contributions to differences 
in mortality before (January 2000 to December 2016) and after (January 2008 to March 2010) introduction of the National Hip Fracture Database 
(NHFD) and clinical audit alone in 2007, ‘NHFD introduced’; and before (January 2008 to March 2010) and after (April 2010 to December 2016) formal 
introduction of payment penalties under the Best Practice Tariff alone in 2010, ‘BPT introduced’
Scotland England NHFD introduced BPT introduced Intervention overall
2000 to  
2006
2007 to  
2009
2010 to  
2016
2000 to  
2006
2007 to  
2009
2010 to  
2016
DID 95% CI p-value DID 95% CI p-value DID 95% CI p-value
Mortality, %
30-day 9.8 8.8 8.5 9.8 8.7 6.8 -0.1 0.5 to 0.5 0.987 1.6 2.1 to 1.2 < 0.001 1.7 2.0 to 1.2 < 0.001
60-day 15.4 13.8 13.1 15.6 14.0 11.4 0.0 0.6 to 0.6 0.994 1.9 2.5 to 1.3 < 0.001 1.9 2.3 to 1.4 < 0.001
90-day 18.9 17.3 16.4 19.4 17.6 14.7 -0.2 0.9 to 0.5 0.581 2.0 2.6 to 1.3 < 0.001 2.2 2.6 to 1.6 < 0.001
365-day 32.0 30.4 29.8 31.9 30.2 27.8 -0.1 1.0 to 0.6 0.688 1.8 2.5 to 1.0 < 0.001 1.9 2.5 to 1.3 < 0.001
Re-admission, %
30-day 11.1 11.9 12.2 20.5 20.0 21.0 -1.3 1.9 to 0.6 < 0.001 0.7 0.1 to 1.4 0.051 0.6% 1.1 to 0.1 0.038
Length of stay
50th percentile 20.0 21.0 20.0 17.0 14.0 12.0 -4.0 -4.4 to -3.6 < 0.001 -1.0 -1.4 to -0.6 < 0.001 -5.0 -5.3 to -4.7 < 0.001
60th percentile 28.0 29.0 26.0 21.0 18.0 15.0 -4.0 -4.4 to -3.6 < 0.001 0.0 -0.1 to 0.1 0.999 -4.0 -4.2 to -3.8 < 0.001
70th percentile 38.0 39.0 36.0 28.0 22.0 19.0 -7.0 -7.5 to -6.5 < 0.001 0.0 -0.2 to 0.2 0.999 -7.0 -7.2 to -6.8 < 0.001
80th percentile 53.0 54.0 50.0 37.0 30.0 25.0 -8.0 -9.1 to -6.9 < 0.001 -1.0 -1.7 to -0.3 0.008 -9.0 -9.7 to -8.3 < 0.001
CI, confidence interval
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Fig. 1c
Charts showing monthly changes in a) 30-, b) 90- and c) 365-day mortality among adults aged more than 60 years, 2000 to 2016. Dashed lines repre-
sent introduction of the National Hip Fracture Database in January 2007 and the Best Practice Tariff in April 2010. 
Fig. 1a
Fig. 1b
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corroborated these findings, suggesting an overall reduction 
in 30-day mortality in England relative to Scotland of -1.7 
percentage-points (95% CI -2.0 to -1.2). When stratified by 
each component of the intervention alone, the results sug-
gest a modest reduction in 30-day mortality following NHFD 
 introduction that did not reach significance (-0.1 (-0.5 to +0.5) 
percentage-points; p = 0.987) and a larger significant change 
of -1.6 percentage-points (-2.1 to -1.2) following introduction 
of the BPT. Between 2010 and 2016 in England (Fig. 1a), there 
were 7600 fewer deaths than expected within 30 days, follow-
ing implementation of the BPT.
The effects on 60-day mortality showed the same direc-
tion and magnitude as on 30-day mortality (Fig. 1a). Figure 
1b shows similar findings for 90-day mortality, although the 
effect of the BPT was more apparent at this time. DID analysis 
suggested that the combined intervention was associated with a 
change of -2.2 percentage-points (95% CI -2.6 to -1.6). How-
ever, this appeared to be driven entirely by the BPT: NHFD 
DID -0.2 percentage-points (95% CI -0.9 to -0.5) and BPT -2.0 
(-2.6 to -1.3)).
Figure 1c shows that the effect on mortality at 365 days was 
similar to that for mortality at 30 and 60 days. Although a small 
(non-significant; p = 0.688) improvement was observed when 
the NHFD was introduced (DID -0.1 percentage point; 95% CI 
-1.0 to 0.6), the BPT was associated with a significant fall in 
365-day mortality (-1.8; 95% CI -2.5 to -1.0; p < 0.001). The 
effect of the combined intervention on 365-day mortality was 
a change of -1.9 percentage-points (95% CI -2.5 to -1.3). Pro-
jection modelling (presented in Supplementary Figure a) sug-
gests that were the BPT to be implemented in Scotland in 2019, 
upwards of 115 deaths could be prevented each year – a number 
totaling more than 1377 deaths by 2030.
Table II shows that re-admissions at all times (30, 60, 
and 90 days) were increasing steadily in England in the pre- 
implementation phase. The annual trend towards increasing 
30-day re-admissions (0.4 percentage-points; 95% CI 0.3 to 0.5) 
was, however, reversed on implementation of the BPT (instant 
change -1.3 percentage points; 95% CI -2.2 to -0.5) and this 
decline continued each year subsequently (annual trend post- 
implementation -0.2 percentage points; 95% CI -0.4 to -0.1). 
Similar findings were observed for 60- and 90-day re-admissions, 
although the annual trend post-implementation did not change 
after the sudden fall associated with the BPT at these timepoints.
There was an annual trend towards fewer patients undergoing 
surgery within 36 hours in the pre-intervention period (annual 
trend -0.6 percentage-points; 95% CI -0.9 to -0.4). However, in 
the year following introduction of the NHFD/BPT, the propor-
tion of patients reaching the operating theatre within this time-
frame increased by an absolute value of 15.4 percentage-points 
(95% CI 13.7 to 17.0; Table II). This positive trend continued 
to increase by 0.7 percentage-points (95% CI 0.5 to 0.8) each 
year thereafter. Projection modelling (presented in Supplemen-
tary Figure a) suggests that were the BPT to be implemented in 
Scotland starting in 2019, upwards of 220 fewer re-admissions 
within 30 days would be expected among Scottish hip fracture 
patients by 2030.
The median LOS was declining modestly (annual trend -0.6 
days; 95% CI -0.2 to 0.0) in the pre-intervention period. This 
reduction increased following implementation of the NHFD/
BPT (instant change following policy implementation -2.8 
days; 95% CI -3.5 to -2.1; annual trend post-policy implemen-
tation: -0.4 days; 95% CI -0.5 to -0.3) The magnitude of these 
reductions increased in a stepwise manner with each ascending 
quantile (e.g. 60th, 70th, and 80th) so that the largest reduc-
tions were observed amongst the patients with greatest initial 
LOS (80th percentile instant change: -7.3 days; 95% CI -8.8 to 
-5.8; annual trend post-implementation -1.0 days, 95% CI -1.2 
to -0.8).
Discussion
This study provides evidence that the BPT drove changes in 
practice that reduced mortality for elderly patients with a hip 
fracture in England by as many as 7600 fewer deaths within 
30 days between 2010 and 2016. It also suggests that the BPT 
increased the proportion of patients receiving an operation 
within 36 hours, shortened LOS, and reduced re-admissions 
within 30, 60, and 90 days.
A number of small studies have reported improved compli-
ance with measures that were associated with introduction of 
the NHFD24 and BPT.25-27 The NHFD annual reports have also 
shown that English hospitals are increasingly achieving the hip 
fracture national clinical standards.8 One national study reported 
that mortality fell from 10.9% before the NHFD was launched 
to 8.5% afterwards.9 However, this study did not include a con-
trol population or analyze data after the BPT came into effect. 
Our data suggest that there was a gradual trend towards reduced 
mortality between 2007 and 2010 but that this was also appar-
ent, albeit to a lesser extent, in Scotland, which did not partic-
ipate in the NHFD. DID results restricted to the influence of 
the NHFD suggest that the differential trend between the two 
countries was not statistically significant following introduction 
of the NHFD in isolation. There was, however, a significant 
change leading up to full BPT implementation in 2010. DID 
results comparing BPT implementation alone between England 
and Scotland revealed a 2.0 percentage-point reduction in 
90-day mortality (8.7% to 6.8% in England) that accounted for 
90.9% of the overall effect (DID -2.2 percentage-points; 9.8% 
to 6.8% in England).
There are a number of changes that could account for 
improved outcomes over time across the United Kingdom, 
including publication of the BOA/BGS guidelines,28 increas-
ing recognition of the need for early surgery and postoperative 
rehabilitation,29 and the emergence of orthogeriatrics as a med-
ical subspecialty dedicated to caring for elderly patients with a 
fracture.30,31 It therefore seems unlikely that the NHFD alone 
accounted for the fall in mortality reported by Neuburger et al.9 
Although our findings suggest that the NHFD might have had a 
small positive effect on English hip fracture outcomes, this was 
not statistically significant. However, implementation of the 
BPT was associated with a marked and sustained improvement 
in outcomes. It is nevertheless worth noting that the NHFD was 
a prerequisite for the choice of hip fracture outcomes as a tar-
get for pay-for-performance in England and so these two inter-
ventions are fundamentally linked.32 However, our data suggest 
that a system for rewarding best practice can improve outcomes 
beyond that of a voluntary audit of national clinical standards.
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The improvements in LOS and re-admission suggest sub-
stantial resource savings attributable to the BPT in addition to 
reduced mortality.4,6 Importantly, the BPT itself did not require 
a substantial investment. It was initially set up as a payment of 
£445 ($570), which was based on an estimate of the cost that 
an average hospital was likely to incur to provide additional 
operating capacity. However, the base tariff was reduced ini-
tially to adjust for compliance with the BPT criteria that was 
already present throughout the NHS. As a consequence of the 
falling base tariff, the BPT has accounted for a greater propor-
tion of the overall payment to hospitals each year – from £445 
($570) in 2010/11 to £890 ($1141) in 2011/12, £1335 ($1712) 
in 2012/13, and £1353 ($1735) in 2016/17.32 As 100% com-
pliance with the standards has not been achieved, the overall 
payment nationally by CCGs changed little during the first 
three years. Although we have not presented a formal health 
economic analysis, it is likely that the BPT delivered improved 
hip fracture care at reduced cost to NHS commissioners. There 
is a rectification process in the NHS of hospital trusts returning 
reference costs, for the delivery of care, to ensure alignment 
between tariff price and the average cost of delivery.
Previous evaluations of pay-for-performance initiatives have 
reported mixed findings.4,6 Many early studies focused on ‘Val-
ue-Based Purchasing’ (VBP), which is a strategy used by the 
Centers for Medicare and Medicaid Services (CMS) in the United 
States. The VBP programme withholds 2% of annual Medicare 
payments and allocates these to hospitals based on the quality of 
care, compliance with best clinical practice, and patient expe-
rience.33 However, few studies have been able to demonstrate 
improvements in mortality or re-admissions that may be attrib-
utable to VBP.34-36 A similar scheme in the northwest region of 
England (‘Advancing Quality’) was found to have no long-term 
effect on 30-day mortality.37 A number of explanations have 
been proposed for this finding.38 First, the financial impact of 
the VBP is small (average $213 000 bonus and $1 200 000 pen-
alty per hospital in 2015),39 which might be insufficient to moti-
vate changes in clinical pathways given that only a proportion of 
patients in the United States are funded through CMS. Second, 
there are 21 individual measures and improving these in isola-
tion is unlikely to improve a hospital’s overall score.40 Third, 
the financial reward for improvement is unclear until the end 
of the performance period because the scheme is designed to 
be cost-neutral and to transfer payments from low- to high-per-
formers.38 By contrast, the Hip Fracture BPT overcomes many 
of these criticisms as it has a simple design, focuses on a small 
number of high-value measures and carries a financial incen-
tive that may be sufficient to motivate changes.41 An alternative 
explanation for the success of the BPT is that it was part of a 
more complex intervention that began with the national clinical 
audit and NHFD. There is evidence that some hospitals engaged 
with the NHFD from 2007, by designing quality improvement 
processes, aimed at improving their performance using data pro-
vided through online visual dashboards and in publicly acces-
sible reports.8,24 It is possible that the BPT provided additional 
impetus that helped clinicians and hospital leaders to create 
business cases that justified local investment in hip fracture 
services. Our study provides evidence that, despite concerns 
about the success of other schemes, it is possible to improve hip 
fracture outcomes through pay-for- performance. Further work 
should aim to identify the features that distinguish programmes 
that can demonstrably improve outcomes.
The apparent success of the Hip Fracture BPT in England 
could have policy implications for a number of countries. First, 
although there are 36 national clinical audits that are operated 
by the Healthcare Quality Improvement Program (HQIP)42 
in England, there are only 21 BPTs that are used by NHS 
England to refine healthcare payments.43 This suggests that 
there are further opportunities to extend pay-for-performance 
to other groups of patients in England. Second, our findings 
raise the possibility that the introduction of a comparable pay-
for- performance initiative might reduce mortality following hip 
fracture in Scotland. Finally, this study might encourage policy 
makers outside the United Kingdom to consider implementing 
pay-for-performance programmes to improve hip fracture out-
comes. For example, although the CMS coordinates health pay-
ments for most patients aged more than 65 years in the United 
States, the VBP programme does not yet extend to hip frac-
tures. There are more than 200 000 hip fractures in the United 
States each year44,45 with a reported mortality of 5.2% at 30 
days.44 If the estimated benefits of the BPT in England were 
generalizable to the United States, the CMS expansion of pay-
for- performance to elderly patients with a hip fracture could 
prevent as many as 3600 deaths per year.
The strengths of this study are the use of comprehensive 
national cohorts linked to death certificate registrations and 
a ‘control’ region, which overcame the limitations of earlier 
before-and-after studies. There are, however, a number of pos-
sible limitations to this approach. First, our study would still be 
vulnerable to confounding factors if another event had occurred 
at the same time as the NHFD/BPT but only affected outcomes 
in either England or Scotland.12 We are not aware of any such 
events and the factors that are thought to have driven recent 
trends towards improved hip fracture outcomes, such as the rise 
of orthogeriatrics as a medical subspecialty,31 would be expected 
to have applied across the whole of the United Kingdom. 
Although there was a reconfiguration of major trauma services 
in England (but not Scotland) from April 2012, this did not have 
a measurable effect on the quality of hip fracture care.46 Sec-
ond, we did not have access to some variables, such as LOS, 
in Scottish data and so were limited to undertaking ITSA with-
out a control region for these outcomes. As discussed above, 
the absence of a control can result in erroneous attribution of 
change to a single intervention.12 It is, however, reassuring that 
the findings from ITSA for the other outcomes were consist-
ent with those of the DID analyses. A lack of variables also 
restricted our ability to present baseline characteristics for hip 
fracture patients in England and Scotland. Some variables from 
SMR01, such as age, were categorized by the data owners to 
preserve the anonymity of patients and others, such as index 
of multiple deprivation (IMD), were available for England but 
not Scotland. However, this limitation is partly accounted for 
by the study design as there is no obvious reason why differ-
ences in patient characteristics should have changed between 
the pre-intervention period (when outcome trends were paral-
lel) and post-intervention period (when trends diverged). Third, 
we selected outcomes that could be readily quantified using 
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administrative data. Although mortality and re-admissions are 
important quality metrics, other outcomes such as pain, mobil-
ity, and health-related quality of life might be more important 
to patients.47 Finally, we focused on hip fracture outcomes and 
so could not determine whether the BPT had an effect on other 
groups of patients. Unintended consequences of the BPT could 
include the deprioritization of other elderly patients with lower 
limb injuries, such as of the distal femur or ankle, who share 
many vulnerabilities as those with a hip fracture.48,49 Alterna-
tively, further benefits might extend to such patients (a so-called 
‘halo effect’) as hospitals are likely to have invested in orthog-
eriatricians and dedicated trauma operating theatres in order to 
achieve the BPT. The effect of pay-for-performance on related 
groups patients should be a focus for future research. 
In conclusion, this study provides evidence that the Hip 
Fracture BPT improved hip fracture outcomes in England. It 
is therefore possible that BPTs could improve outcomes and 
reduce costs in other disease groups. Policymakers and clini-
cians should support the controlled expansion of the BPT model 
to other clinical areas and health policy environments. 
Take home message
- The Hip Fracture Best Practice Tariff (BPT) was associated 
with reduced mortality for elderly patients with a hip fracture 
in England.
- The BPT may also have driven changes that increased the proportion of 
patients receiving prompt surgery, shortened length of stay, and reduced 
hospital re-admissions.
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Supplementary material
A table summarizing eligibility for payment of the Best 
Practice Tariff, as well as a figure showing the projected 
reductions in 30-day mortality, 365-day mortality, and 
30-day re-admission were the Best Practice Tariff to be intro-
duced in Scotland in 2019.
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